Search results for "Prescribing Buprenorphine"
Big barrier to buprenorphine removed
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
https://immattersacp.org/archives/2023/03/big-barrier-to-buprenorphine-removed.htm
1 Mar 2023
ACP's Pain Management Learning Hub releases new learning materials
Each of the new peer-to-peer activities provides opportunities for ACP members to earn free CME/MOC credit and meet many state-based CME requirements.
https://immattersacp.org/weekly/archives/2022/02/01/6.htm
1 Feb 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/03/latest-updates-on-acps-priorities-initiatives.htm
1 Mar 2022
Register now for ACP's one-day course on pain management in an environment of opioid de-escalation
The virtual course on Tuesday, Oct. 5, will provide education for internists on the latest strategies and best practices in pain management.
https://immattersacp.org/weekly/archives/2021/09/21/5.htm
21 Sep 2021
Learn the latest on excessive alcohol use, opioid use disorder
This month's issue addresses alcohol use and misuse, prescribing buprenorphine, and improving health care's response to future pandemics.
https://immattersacp.org/archives/2023/03/learn-the-latest-on-excessive-alcohol-use-opioid-use-disorder.htm
1 Mar 2023
One-third of primary care physicians do not support medications for opioid use disorder
Fewer than a quarter of surveyed primary care physicians expressed interest in treating patients with opioid use disorder, and only 11.8% were interested in obtaining a waiver to prescribe buprenorphine.
https://immattersacp.org/weekly/archives/2020/04/21/2.htm
21 Apr 2020
High-dose opioid use dropping in the VA, but opioids frequently discontinued involuntarily, studies find
Recent studies from the Veterans Health Administration looked at voluntary and involuntary opioid reduction; high-dose, long-term opioid therapy; and quality improvement efforts for opioid use disorder treatment.
https://immattersacp.org/weekly/archives/2020/11/10/2.htm
10 Nov 2020
Q&A: DEA requires addiction training for all prescribers
The Drug Enforcement Administration is requiring eight hours of training related to substance use disorder treatment, sending clinicians scurrying to their continuing education providers for help.
https://immattersacp.org/archives/2023/05/dea-requires-addiction-training-for-all-prescribers.htm
1 May 2023
Stepping up to treat osteoporosis
This month's issue addresses osteoporosis, transient ischemic attacks, and another edition of I.M. Ready columns for early career physicians.
https://immattersacp.org/archives/2023/05/stepping-up-to-treat-osteoporosis.htm
1 May 2023
Breaking barriers to buprenorphine
Despite heightened awareness of the opioid crisis, treatment still eludes many patients who are struggling with addiction.
https://immattersacp.org/archives/2018/09/breaking-barriers-to-buprenorphine.htm
1 Sep 2018